The Formula Behind Billionaire’s 30-Year Win Streak
Stanley Druckenmiller may be best known for his role with George Soros in shorting the British pound in 1992, which famously became known as breaking the Bank of England. That position resulted in a cumulative profit of over a billion dollars, and all while Druckenmiller was only in his late 30s.
At a time when many professional investors consider themselves in their early innings of their careers, » Read more about: The Formula Behind Billionaire’s 30-Year Win Streak »
Read More
60.2% Upside In This Forgotten Favorite
When we wrote about Apple’s bullish opportunity frankly we weren’t expecting it to be the only stock that held up in the market but the graphic below highlights just how awful Friday’s market was and how nothing escaped the onslaught but the Cupertino giant.
But what other stock could be on the verge of rising after a period of sustained underperformance?
» Read more about: 60.2% Upside In This Forgotten Favorite »
Read More
Red Hot Inflation, Volatility Soars And Scary Prediction
When the CPI news hit the wires, the market immediately started to sell off on Wednesday. Concerns rose that inflation, which many thought had tempered, was in fact red hot.
Translation: The Federal Reserve would be less likely to cut rates. And since rate cuts have been priced in, the only way for the market to go was down,
» Read more about: Red Hot Inflation, Volatility Soars And Scary Prediction »
Read More
Is a 34.6% Annual Return a Slam Dunk?
The old fox Warren Buffett might still have the midas touch after all. One of his favorite stocks in recent years has been Occidental Petroleum, and it’s been on a tear recently.
A quick look at the chart reveals that the stock has broken out to the upside, above an old yet key resistance level.
» Read more about: Is a 34.6% Annual Return a Slam Dunk? »
Read More
3 Top Quantum Stocks to Buy
The last several years have seen a series of tech cycles drive up the stock market. From Metaverse technology to the rise of generative AI, everyone from retail investors to hedge fund managers is looking to get in on the next huge tech development.
Going into 2025, it appears that the technology to go long on may be quantum computing.
» Read more about: 3 Top Quantum Stocks to Buy »
Read MoreThe Burst
1 Organ Transplant Disruptor to Buy on the Dip
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry.
The company’s unique organ care system technology protects and monitors donor organs before they are transplanted into patients, resulting in improved organ health and outcomes. TransMedics also provides logistical services,
» Read more about: 1 Organ Transplant Disruptor to Buy on the Dip »
Read MoreThe Spotlight
1 Top Healthcare Firm Set To Pop
UnitedHealth Group, with a market capitalization of around $454 billion, is the largest health insurer in the United States, serving nearly 50 million Americans.
It benefits from unparalleled market presence and scale that grants it significant bargaining power, which in turn ensures lower costs and higher margins compared to its competitors.
Over the past decade,
» Read more about: 1 Top Healthcare Firm Set To Pop »
Read MoreThe Daily
The 7 Best Monthly Dividend ETFs to Buy Today
The two most important potential benefits of securities investing are capital appreciation and current income. Capital appreciation usually occurs when the inherent value of a security increases and its market value rises accordingly. Current income comes in the form of regular dividend payments.
Significant capital appreciation can happen very quickly — it’s not unheard of for a stock,
» Read more about: The 7 Best Monthly Dividend ETFs to Buy Today »